Clinical outcome of adjuvant endocrine treatment according to Her-2/neu status in breast cancer

BACKGROUND & OBJECTIVES: An association between over-expression of proto-oncogene Her-2/neu and resistance to tamoxifen in estrogen receptor (ER) positive, primary and metastatic breast cancer has been suggested. HR+/Her-2/neu+ patients have a poor response to endocrine therapy, making this grou...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: James, Rani, Thriveni, K., Krishnamoorthy, Lakshmi, Deshmane, Vijayalaxmi, Bapsy, P.P., Ramaswamy, Girija
Format: Artigo
Idioma:Inglês
Publicat: Medknow Publications 2011
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3100149/
https://ncbi.nlm.nih.gov/pubmed/21321422
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars